Compare Canopy Growth Corp (CGC) vs Progressive Corp (PGR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Canopy Growth Corp vs Progressive Corp — how do they compare? Canopy Growth Corp trades at $1.02 (market cap $430.60M), while Progressive Corp trades at $209.77 (market cap $120.56B). The key difference: Progressive Corp is far larger — about 280× Canopy Growth Corp's market cap, and Progressive Corp pays a 0.19% dividend while Canopy Growth Corp pays none. Which is the better fit depends on your goals.
| CGC | PGR | |
|---|---|---|
Market Cap | $430.60M | $120.56B |
Sector | Health | Financials |
52-Week High | $1.92 | $252.68 |
52-Week Low | $0.86 | $190.40 |
Enterprise Value | $388.01M | $128.77B |
Dividend Yield | — | 0.19% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CGC trades at $1.01, up 1.0% in the last session, with a bullish technical signal from moving averages but overbought RSI readings. The company reported Q1 fiscal 2027 revenue growth of 13% year-over-year, beating estimates, yet continues to post net losses. Recent news highlights expansion in European medical cannabis markets and cost-cutting efforts, while analyst consensus is mixed with 33% buy ratings.
Outlook remains speculative with high execution risk; improving cash flow trends and potential U.S. rescheduling offer upside, but persistent negative margins and debt concerns weigh on equity value. Investors should weigh growth prospects against profitability challenges in the volatile cannabis sector.
PGR trades at $208.87, down 1.64% over 24 hours, with technical indicators signaling a bearish trend. The stock shows strong fundamentals, including a P/E of 10.4, net income margin of 12.85%, and robust revenue growth from $49.6B in 2022 to $87.6B in 2025. Recent Q2 2026 earnings beat expectations at $4.85 EPS, but analyst sentiment is mixed amid a widening combined ratio reported in August 2026.
The outlook for PGR is cautiously optimistic, supported by solid profitability and growth, though near-term technical weakness and competitive pressures pose risks. Upside exists if the company maintains earnings momentum, with a consensus price target of $231.20 offering potential appreciation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Canopy Growth Corp
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
Read more on CGC →About Progressive Corp
Progressive underwrites private and commercial auto insurance and specialty lines
Read more on PGR →
